Literature DB >> 22116801

General and respiratory health outcomes in adult survivors of bronchopulmonary dysplasia: a systematic review.

Aisling Gough1, Dale Spence1, Mark Linden1, Henry L Halliday2, Lorcan P A McGarvey3.   

Abstract

BACKGROUND: The purpose of this systematic literature review was to examine current empirical research on general and respiratory health outcomes in adult survivors of bronchopulmonary dysplasia (BPD).
METHODS: We searched seven databases up to the end of November 2010 (MEDLINE, PubMed, EMBASE, PsycINFO, Maternity and Infant Care, Cumulative Index of Nursing and Allied Health Literature, and Web of Knowledge). We independently screened and included only those studies concerning the assessment of outcome measures in adult survivors of BPD. Data on methodologic design and findings were extracted from each included study; in addition, the methodologic quality of each study was assessed using the Critical Appraisal Skills Programme checklist.
RESULTS: Fourteen cohort studies met the review criteria. Of those, a total of eight studies were considered to be of high quality (score 9-12), five of moderate quality (score 5-8), and only one was of low quality (score 0-4). In all studies of adult survivors of BPD, differences were found between the index and control groups, suggesting that many adults survivors of BPD who were born preterm or with very low birth weight had more respiratory symptoms and pulmonary function abnormalities compared with their peers. Five studies concerning radiologic findings reported structural changes persisting into adulthood. Findings from three studies suggested impairment in exercise capacity, although firm conclusions were limited by the small sample size in the studies reviewed.
CONCLUSIONS: Compared with adults born at term, adult survivors of BPD have more impairment in general and respiratory health, which does not seem to diminish over time.

Entities:  

Mesh:

Year:  2011        PMID: 22116801     DOI: 10.1378/chest.11-1306

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  37 in total

Review 1.  Frontiers in pulmonary hypertension in infants and children with bronchopulmonary dysplasia.

Authors:  Joseph M Collaco; Lewis H Romer; Bridget D Stuart; John D Coulson; Allen D Everett; Edward E Lawson; Joel I Brenner; Anna T Brown; Melanie K Nies; Priya Sekar; Lawrence M Nogee; Sharon A McGrath-Morrow
Journal:  Pediatr Pulmonol       Date:  2012-07-06

2.  Relationship of structural to functional impairment during alveolar-capillary membrane development.

Authors:  Shawn K Ahlfeld; Yong Gao; Simon J Conway; Robert S Tepper
Journal:  Am J Pathol       Date:  2015-02-03       Impact factor: 4.307

3.  Cumulative effects of neonatal hyperoxia on murine alveolar structure and function.

Authors:  Angela M Cox; Yong Gao; Anne-Karina T Perl; Robert S Tepper; Shawn K Ahlfeld
Journal:  Pediatr Pulmonol       Date:  2017-02-10

4.  A 24-year-old woman with episodes of shortness of breath, cough and wheezing.

Authors:  Vivek Dhawan; Meena Kalluri
Journal:  CMAJ       Date:  2013-04-08       Impact factor: 8.262

Review 5.  Bronchopulmonary dysplasia and pulmonary hypertension: a meta-analysis.

Authors:  G Al-Ghanem; P Shah; S Thomas; L Banfield; S El Helou; C Fusch; A Mukerji
Journal:  J Perinatol       Date:  2017-01-12       Impact factor: 2.521

Review 6.  Assessment of inhibited alveolar-capillary membrane structural development and function in bronchopulmonary dysplasia.

Authors:  Shawn K Ahlfeld; Simon J Conway
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2014-03-06

7.  Respiratory and Cardiovascular Outcomes in Survivors of Extremely Preterm Birth at 19 Years.

Authors:  John R Hurst; Joanne Beckmann; Yanyan Ni; Charlotte E Bolton; Carmel M McEniery; John R Cockcroft; Neil Marlow
Journal:  Am J Respir Crit Care Med       Date:  2020-08-01       Impact factor: 21.405

Review 8.  Ventilatory control in infants, children, and adults with bronchopulmonary dysplasia.

Authors:  Melissa L Bates; De-Ann M Pillers; Mari Palta; Emily T Farrell; Marlowe W Eldridge
Journal:  Respir Physiol Neurobiol       Date:  2013-07-22       Impact factor: 1.931

9.  Therapeutic effects of fibroblast growth factor-10 on hyperoxia-induced bronchopulmonary dysplasia in neonatal mice.

Authors:  Tao Han; Ming Chi; Yan Wang; Yabo Mei; Qiuping Li; Mengnan Yu; Qianqian Ma; Yuhan Chen; Zhichun Feng
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

Review 10.  Pulmonary hypertension in bronchopulmonary dysplasia.

Authors:  Sara K Berkelhamer; Karen K Mestan; Robin H Steinhorn
Journal:  Semin Perinatol       Date:  2013-04       Impact factor: 3.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.